Detection and isolation of SARS‐CoV‐2 Eta variant from the international travelers and local residents of India. Issue 7 (7th March 2022)

• Record Type: Journal Article
• Authors: Yadav, Pragya D.; Nyayanit, Dimpal A.; Gupta, Nivedita; Shastri, Jayanthi; Sahay, Rima R.; Patil, Deepak Y.; M. Shete, Anita; Razdan, Alpana; Agrawal, Sachee; Kumar, Abhinendra; Majumdar, Triparna; Patil, Savita; Sarkale, Prasad; Baradkar, Shreekant; Dudhmal, Manisha; Kaur, Harmanmeet; Aggarwal, Neeraj
• Is Part Of: Journal of medical virology. Volume 94:Issue 7(2022)
• Page Start: 3404
• Page End: 3409
• Publication Date: 2022-03-07
• Subjects: Eta -- India -- SARS‐CoV‐2 -- variant under monitoring; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.27676
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract: International travel has been the major source for the rapid spread of new SARS‐CoV‐2 variants across the globe. During SARS‐CoV‐2 genomic surveillance, a total of 212 SARS‐CoV‐2 positive clinical specimens were sequenced using next‐generation sequencing. A complete SARS‐CoV‐2 genome could be retrieved from 90 clinical specimens. Of them, 14 sequences belonged to the Eta variant from clinical specimens of international travelers ( n = 12) and local residents ( n = 2) of India, and 76 belonged to other SARS‐CoV‐2 variants. Of all the Eta‐positive specimens, the virus isolates were obtained from the clinical specimens of six international travelers. Many variants of interest have been found to cause substantial community transmission or cluster infections. The detection of this variant with lethal E484K mutation across the globe and India necessitates persistent genomic surveillance of the SARS‐CoV‐2 variants, which would aid in taking preventive action.